The reliability of the IL-6, sIL-6R and sgp130 response to a preloaded time trial

被引:0
|
作者
I. Walshe
P. Robson-Ansley
A. St Clair Gibson
C. Lawrence
K. G. Thompson
L. Ansley
机构
[1] Northumbria University,Department of Sport and Exercise Sciences
[2] GlaxoSmithKline Nutritional Healthcare R&D,undefined
来源
关键词
Exercise; IL-6; sIL-6R; Time trial; Reliability;
D O I
暂无
中图分类号
学科分类号
摘要
Interleukin-6 (IL-6) is a cytokine that can mediate numerous biological actions including fatigue. Circulating IL-6 increases during prolonged exercise, and furthermore, the signalling receptors sIL-6R and sgp130 are also increased. The variability of the response of these markers to exercise is unknown; therefore, we examined the changes in these markers to a preloaded time trial bout of running. Nine males performed three identical trials where participants ran at 60% \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ v\dot{V}{\text{O}}_{{ 2 {\text{max}}}} $$\end{document} for 2 h interspersed with 30 s at 90% \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ v\dot{V}{\text{O}}_{{ 2 {\text{max}}}} $$\end{document} every 10 min, followed by a 5-km time trial. Blood samples were drawn at baseline, following the 2-h bout, post time trial, 1 h post time trial and the following morning. Results showed that between-subject variability (CVg) was greater than within-subject variation (CVi) for the three markers. IL-6, sIL-6R and sgp130 demonstrated a CVi of 15.3–25.5%, 15.0–17.6% and 6.2–9.4% variation, respectively, across the time points. When the data from the second and third trials were analysed independently, CVi was reduced which is supported by the time trial results for which CVi improve (4.7–2.4%). In conclusion, the results indicate that a large variation in response to exercise can be reduced following a habituation trial.
引用
收藏
页码:619 / 625
页数:6
相关论文
共 50 条
  • [31] The effect of IL-6 and sIL-6R on the expression of cartilage matrix proteins
    Namba, A.
    Aida, Y.
    Watanabe, Y.
    Tanaka, H.
    Shimizu, O.
    Suzuki, N.
    Maeno, M.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S266 - S266
  • [32] The IL-6/sIL-6R complex as a novel target for therapeutic approaches
    Rose-John, Stefan
    Waetzig, Georg H.
    Scheller, Juergen
    Groetzinger, Joachim
    Seegert, Dirk
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (05) : 613 - 624
  • [33] High ratio of serum soluble interleukin-6 receptor (sIL-6R) to soluble glycoprotein 130 (sgp130) at diagnosis predicts poor prognosis in multiple myeloma (MM)
    Pelliniemi, TT
    Hirvonen, H
    Laakso, M
    Lahtinen, R
    Leino, A
    Rajamaki, A
    Tienhaara, A
    Pulkki, K
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 619 - 619
  • [34] Treatment with beta-interferon produces up-regulation of the soluble interleukin-6 receptor sIL-6R but not sgp130 in multiple sclerosis patients
    Allen, J
    Gibbs, E
    Aziz, T
    Oger, J
    MULTIPLE SCLEROSIS, 2005, 11 : S82 - S82
  • [35] Combined effect of reduced glutathione and ulinastatin on the expressions of IL-6, sIL-6 and sgp130 in peripheral blood of paraquat-poisoned patients
    Wang, Jianghai
    Sun, Hongting
    Fang, Lihua
    Si, Xuepeng
    Li, Liang
    Han, Wang
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2021, 20 (04) : 735 - 740
  • [36] The effect of IL-6 and sIL-6R on liver progenitor oval cell biology
    Matthews, Vance B.
    Rose-John, Stefan
    Yeoh, George C.
    INFLAMMATION RESEARCH, 2005, 54 : S160 - S161
  • [37] Clazakizumab (CLZ, Anti-IL-6 Antibody) and Tocilizumab (TCZ, Anti-IL-6 Receptor [r] Antibody) Treatments Differentially Affect IL-6/IL-6R Signaling by Modulating Soluble IL-6R (sIL-6R) and gp130 (sgp130) in Kidney Transplant Patients (KTx Pts) Treated for Chronic Antibody-Mediated Rejection (cABMR).
    Shin, B.
    Ge, S.
    Petrosyan, A.
    Ammerman, N. F.
    Vo, A. A.
    Jordan, S. C.
    Toyoda, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 452 - 452
  • [38] IL-6/SOLUBLE IL-6-RECEPTOR (SIL-6R) MEDIATE 2 DISTINCT SIGNALING PATHWAYS IN OSTEOBLASTS THROUGH GP130
    NISHIMURA, R
    YASUKAWA, K
    MUNDY, GR
    YONEDA, T
    JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 : S158 - S158
  • [39] 消化道肿瘤患者外周血T细胞亚群与IL-6及其sIL-6Rα、sIL-6Rβ的检测
    尚佳
    周炳喜
    蒋仪锋
    杨玉秀
    上海免疫学杂志, 2001, (01) : 56 - 56
  • [40] The effects of anticoagulation and processing on assays of IL-6, sIL-6R, sIL-2R and soluble transferrin receptor
    DeJongh, R
    Vranken, J
    Vundelinckx, G
    Bosmans, E
    Maes, M
    Heylen, R
    CYTOKINE, 1997, 9 (09) : 696 - 701